Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study
| Image |  |
|---|---|
| Description | scholarly article by Austin G Kulasekararaj et al published 7 February 2019 in Blood |
| Author/s |
author: Régis Peffault de Latour |
| Publication date | February 7, 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |